Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209585 · ClinicalTrials.gov registry record
A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 23
- Enrollment target
NCT01209585: Completed study, sponsored by MedImmune.
NCT01209585 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01209585 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to study the evaluation of blood samples and blood types to identify functional protein in the joints.
Primary Outcome
Data analyses on model devlopment to maximize measures of predictive diagnostic accuracy, etc.
Interventions
- OTHER Blood samples
- OTHER Synovial fluid aspiration
- OTHER Synovial tissue sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-03 |
What the finished NCT01209585 record still lists
NCT01209585 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood samples is the first listed.
NCT01209585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01209585 about?
NCT01209585 is a clinical study titled "A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis". The purpose of this study is to study the evaluation of blood samples and blood types to identify functional protein in the joints.
What is the current status of trial NCT01209585?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2011-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01209585?
The interventions under investigation include: Blood samples (OTHER), Synovial fluid aspiration (OTHER), Synovial tissue sample (OTHER).
Who is sponsoring clinical trial NCT01209585?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia